Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors

被引:45
作者
Wagner, J [1 ]
Kallen, J [1 ]
Ehrhardt, C [1 ]
Evenou, JP [1 ]
Wagner, D [1 ]
机构
[1] Novartis Pharma AG, CH-4002 Basel, Switzerland
关键词
D O I
10.1021/jm981013e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have designed, synthesized, and tested in vitro a novel class of noncovalent thrombin inhibitors. The main feature of these inhibitors is a 6,5-fused bicyclic core structure that fills the S-2 pocket of the active site of thrombin. The bicycle introduces conformational constraint into the ligand and locks the X-aa-Pro amide bond into the desired trans configuration. Among the known ring systems, we selected by molecular modeling the 7-thiaindolizidinones (BTD) as our basic template. The influence of several structural features was analyzed: the length of the argininal side chain, the stereochemistry at C-6, and the importance of making optimal use of the S-3 pocket. Finally, an X-ray crystal structure of inhibitor 15 bound to thrombin was obtained at a resolution of 2.3 Angstrom. These designed thrombin inhibitors, which were prepared by an efficient synthesis, showed high selectivity over trypsin and other serine proteases. Further derivation based on the information obtained by X-ray crystallography should certainly allow to improve the potency.
引用
收藏
页码:3664 / 3674
页数:11
相关论文
共 55 条
[51]   In vitro effects of inogatran, a selective low molecular weight thrombin inhibitor [J].
TegerNilsson, AC ;
Bylund, R ;
Gustafsson, D ;
Gyzander, E ;
Eriksson, U .
THROMBOSIS RESEARCH, 1997, 85 (02) :133-145
[52]   Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site [J].
Tucker, TJ ;
Lumma, WC ;
Mulichak, AM ;
Chen, ZG ;
NaylorOlsen, AM ;
Lewis, SD ;
Lucas, R ;
Freidinger, RM ;
Kuo, LC .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :830-832
[53]   Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy [J].
Tucker, TJ ;
Lumma, WC ;
Lewis, SD ;
Gardell, SJ ;
Lucas, BJ ;
Baskin, EP ;
Woltmann, R ;
Lynch, JJ ;
Lyle, EA ;
Appleby, SD ;
Chen, IW ;
Dancheck, KB ;
Vacca, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (11) :1565-1569
[54]   GEOMETRY OF BINDING OF THE N-ALPHA-TOSYLATED PIPERIDIDES OF META-AMIDINO-PHENYLALANINE, PARA-AMIDINO-PHENYLALANINE AND PARA-GUANIDINO-PHENYLALANINE TO THROMBIN AND TRYPSIN - X-RAY CRYSTAL-STRUCTURES OF THEIR TRYPSIN COMPLEXES AND MODELING OF THEIR THROMBIN COMPLEXES [J].
TURK, D ;
STURZEBECHER, J ;
BODE, W .
FEBS LETTERS, 1991, 287 (1-2) :133-138
[55]  
1996, GENET TECHNOL NEWS, V16, P8